Sphingolipids in multiple sclerosis

NeuroMolecular Medicine

Volumn 12, Issue 4, 2010, Pages 351-361

  Jana, Arundhati ^a   Pahan, Kalipada ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Ceramide; Glial activation; Oligodendroglial apoptosis; Perivascular cuffing; Signal transduction; Sphingomyelinases; Sphingosine 1 phosphate

Indexed keywords

CERAMIDE; CYTOKINE; FAS ANTIGEN; FINGOLIMOD; GALACTOSYLCERAMIDE; GLUTAMATE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTROPHIN RECEPTOR P75; POLYUNSATURATED FATTY ACID; REACTIVE OXYGEN METABOLITE; SPHINGOLIPID; SPHINGOSINE; SULFATIDE; TUMOR NECROSIS FACTOR ALPHA;

ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; AUTOIMMUNITY; CALCIUM TRANSPORT; CELL DIFFERENTIATION; DRUG MECHANISM; GLIOSIS; HUMAN; IMMUNOGENICITY; LIPID METABOLISM; MULTIPLE SCLEROSIS; MYELIN SHEATH; MYELINATION; NERVE CONDUCTION; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CYTOKINES; GLIOSIS; HUMANS; MICE; MULTIPLE SCLEROSIS; MYELIN SHEATH; OLIGODENDROGLIA; OXIDATIVE STRESS; RATS; SIGNAL TRANSDUCTION; SPHINGOLIPIDS;

EID: 78649761056     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12017-010-8128-4     Document Type: Review

References (100)

1. N Abo-Krysha L Rashed 2008 The role of iron dysregulation in the pathogenesis of multiple sclerosis: An Egyptian study Multiple Sclerosis 14 602 608 1:CAS:528:DC%2BD1cXovFCjtro%3D 10.1177/1352458507085550 18408021 (Pubitemid 351954401)
2. E Alberdi MV Sanchez-Gomez A Marino C Matute 2002 Ca(2+) influx through AMPA or kainate receptors alone is sufficient to initiate excitotoxicity in cultured oligodendrocytes Neurobiology of Diseases 9 234 243 1:CAS:528:DC%2BD38XhvVSlu7Y%3D 10.1006/nbdi.2001.0457 (Pubitemid 34261217)
3. SA Back X Gan Y Li PA Rosenberg JJ Volpe 1998 Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion Journal of Neuroscience 18 6241 6253 1:CAS:528: DyaK1cXlsVahtbw%3D 9698317 (Pubitemid 28373231)
4. R Bansal AL Gard SE Pfeiffer 1988 Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid Journal of Neuroscience Research 21 260 267 1:CAS:528:DyaL1MXnt12qsA%3D%3D 10.1002/jnr.490210218 2464078 (Pubitemid 19031351)
5. R Bansal SE Pfeiffer 1989 Reversible inhibition of oligodendrocyte progenitor differentiation by a monoclonal antibody against surface galactolipids Proceedings of the National Academy of Sciences of the United States of America 86 6181 6185 1:CAS:528:DyaL1MXltlWlsL4%3D 10.1073/pnas.86.16. 6181 2668957 (Pubitemid 19210621)
6. N Bartke YA Hannun 2009 Bioactive sphingolipids: Metabolism and function Journal of Lipid Research 50 Suppl S91 S96 10.1194/jlr.R800080-JLR200 19017611
7. G Bartzokis 2004 Age-related myelin breakdown: A developmental model of cognitive decline and Alzheimer's disease Neurobiology of Aging 25 5 18 1:CAS:528:DC%2BD3sXpvVait7w%3D 10.1016/j.neurobiolaging.2003.03.001 14675724 (author reply 49-62) (Pubitemid 37522186)
8. R Bassi V Anelli P Giussani G Tettamanti P Viani L Riboni 2006 Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors Glia 53 621 630 10.1002/glia.20324 16470810
9. NG Bazan 2003 Synaptic lipid signaling: Significance of polyunsaturated fatty acids and platelet-activating factor Journal of Lipid Research 44 2221 2233 1:CAS:528:DC%2BD2cXmsVynuw%3D%3D 10.1194/jlr.R300013-JLR200 13130128 (Pubitemid 38082480)
10. J Beard 2007 Recent evidence from human and animal studies regarding iron status and infant development The Journal of nutrition 137 524S 530S 1:CAS:528:DC%2BD2sXhsVSqs7w%3D 17237340 (Pubitemid 46213476)
11. JL Beard JA Wiesinger JR Connor 2003 Pre- and postweaning iron deficiency alters myelination in Sprague-Dawley rats Developmental Neuroscience 25 308 315 1:CAS:528:DC%2BD3sXovVOgtrg%3D 10.1159/000073507 14614257 (Pubitemid 37465056)
12. EE Benarroch 2009 Oligodendrocytes: Susceptibility to injury and involvement in neurologic disease Neurology 72 1779 1785 10.1212/WNL. 0b013e3181a6b123 19451534
13. EN Benveniste 1997 Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis Journal of Molecular Medicine 75 165 173 1:CAS:528:DyaK2sXisF2gt74%3D 10.1007/s001090050101 9106073 (Pubitemid 27132679)
14. MM Blewett 2008 Hypothesized role of galactocerebroside and NKT cells in the etiology of multiple sclerosis Medical Hypotheses 70 826 830 1:CAS:528:DC%2BD1cXjtVert7Y%3D 10.1016/j.mehy.2007.07.037 17889444 (Pubitemid 351318080)
15. JM Boggs A Menikh G Rangaraj 2000 Trans interactions between galactosylceramide and cerebroside sulfate across apposed bilayers Biophysical Journal 78 874 885 1:CAS:528:DC%2BD3cXhtFKjsL8%3D 10.1016/S0006-3495(00)76645-8 10653800 (Pubitemid 30211845)
16. C Bolton C Paul 2006 Glutamate receptors in neuroinflammatory demyelinating disease Mediators of Inflammation 2006 93684 10.1155/MI/2006/93684 16883070
17. S Brahmachari YK Fung K Pahan 2006 Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide Journal of Neuroscience 26 4930 4939 1:CAS:528:DC%2BD28XkvFSgtbY%3D 10.1523/JNEUROSCI.5480-05.2006 16672668 (Pubitemid 44315335)
18. A Brand E Schonfeld I Isharel E Yavin 2008 Docosahexaenoic acid-dependent iron accumulation in oligodendroglia cells protects from hydrogen peroxide-induced damage Journal of Neurochemistry 105 1325 1335 1:CAS:528:DC%2BD1cXmsVOlsLg%3D 10.1111/j.1471-4159.2008.05234.x 18208540 (Pubitemid 351590796)
19. V Brinkmann 2009 FTY720 (fingolimod) in multiple sclerosis: Therapeutic effects in the immune and the central nervous system British Journal of Pharmacology 158 1173 1182 1:CAS:528:DC%2BD1MXhsVSks7fO 10.1111/j.1476-5381. 2009.00451.x 19814729
20. MJ Carson 2002 Microglia as liaisons between the immune and central nervous systems: Functional implications for multiple sclerosis Glia 40 218 231 10.1002/glia.10145 12379909 (Pubitemid 35337379)
21. JR Connor SL Menzies 1996 Relationship of iron to oligodendrocytes and myelination Glia 17 83 93 1:STN:280:DyaK28znt1OrsQ%3D%3D 10.1002/(SICI)1098- 1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7 8776576 (Pubitemid 26309437)
22. AE Cremesti FM Goni R Kolesnick 2002 Role of sphingomyelinase and ceramide in modulating rafts: Do biophysical properties determine biologic outcome? FEBS Letters 531 47 53 1:CAS:528:DC%2BD38XotVOjtLs%3D 10.1016/S0014-5793(02)03489-0 12401201 (Pubitemid 35232783)
23. TJ Cunningham L Yao M Oetinger L Cort EP Blankenhorn JI Greenstein 2006 Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis Journal of Neuroinflammation 3 26 10.1186/1742-2094-3-26 16965627 (Pubitemid 44575753)
24. SD D'Souza B Bonetti V Balasingam NR Cashman PA Barker AB Troutt CS Raine JP Antel 1996 Multiple sclerosis: Fas signaling in oligodendrocyte cell death The Journal of experimental medicine 184 2361 2370 10.1084/jem.184.6.2361 8976190 (Pubitemid 27023735)
25. BN Dittel 2000 Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis Archivum Immunologiae et Therapiae Experimentali (Warsz) 48 381 388 1:CAS:528:DC%2BD3MXoslGqsw%3D%3D
26. AS Don C Martinez-Lamenca WR Webb RL Proia E Roberts H Rosen 2007 Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues The Journal of biological chemistry 282 15833 15842 1:CAS:528:DC%2BD2sXltl2ns7c%3D 10.1074/jbc.M609124200 17400555 (Pubitemid 47093290)
27. P Dowling X Ming S Raval W Husar P Casaccia-Bonnefil M Chao S Cook B Blumberg 1999 Up-regulated p75NTR neurotrophin receptor on glial cells in MS plaques Neurology 53 1676 1682 1:CAS:528:DyaK1MXnvVKnsrg%3D 10563612 (Pubitemid 29530339)
28. R Dringen PG Pawlowski J Hirrlinger 2005 Peroxide detoxification by brain cells Journal of Neuroscience Research 79 157 165 1:CAS:528: DC%2BD2MXltlCltg%3D%3D 10.1002/jnr.20280 15573410 (Pubitemid 40116430)
29. DM Ferriero 2001 Oxidant mechanisms in neonatal hypoxia-ischemia Developmental Neuroscience 23 198 202 1:CAS:528:DC%2BD3MXnsV2qtbY%3D 10.1159/000046143 11598320 (Pubitemid 34701672)
30. PE Fraser MA Moscarello RP Rand CM Deber 1986 Spontaneous vesicularization of myelin lipids is counteracted by myelin basic protein Biochimica et Biophysica Acta 863 282 288 1:CAS:528:DyaL2sXhtFGnurw%3D 10.1016/0005-2736(86)90268-3 2431713 (Pubitemid 17219338)
31. RS Fujinami MG von Herrath U Christen JL Whitton 2006 Molecular mimicry, bystander activation, or viral persistence: Infections and autoimmune disease Clinical Microbiology Reviews 19 80 94 1:CAS:528:DC%2BD28XhsFGjtb0%3D 10.1128/CMR.19.1.80-94.2006 16418524 (Pubitemid 43157648)
32. Y Gilgun-Sherki E Melamed D Offen 2004 The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy Journal of Neurology 251 261 268 1:CAS:528:DC%2BD2cXjslGju78%3D 10.1007/s00415-004-0348-9 15015004 (Pubitemid 38387142)
33. H Grassme J Bock J Kun E Gulbins, et al. 2002 Clustering of CD40 ligand is required to form a functional contact with CD40 The Journal of biological chemistry 277 30289 30299 1:CAS:528:DC%2BD38XmsVKhtrk%3D 10.1074/jbc.M200494200 12011072
34. H Grassme V Jendrossek J Bock A Riehle E Gulbins, et al. 2002 Ceramide-rich membrane rafts mediate CD40 clustering Journal of Immunology 168 298 307 1:CAS:528:DC%2BD38Xht1Gkuw%3D%3D (Pubitemid 34014130)
35. H Grassme H Schwarz E Gulbins 2001 Molecular mechanisms of ceramide-mediated CD95 clustering Biochemical and Biophysical Research Communications 284 1016 1030 1:CAS:528:DC%2BD3MXktl2msb0%3D 10.1006/bbrc.2001. 5045 11409897 (Pubitemid 32924751)
36. S Greenfield S Brostoff E Hogan 1977 Evidence for defective incorporation of proteins in myelin of the quaking mutant mouse Brain Research 120 507 515 1:STN:280:DyaE2s%2FovVyqtw%3D%3D 10.1016/0006-8993(77)90403-6 832136 (Pubitemid 8016421)
37. B Halliwell 1992 Reactive oxygen species and the central nervous system Journal of Neurochemistry 59 1609 1623 1:CAS:528:DyaK38XmsVKlsbk%3D 10.1111/j.1471-4159.1992.tb10990.x 1402908
38. YA Hannun 1994 The sphingomyelin cycle and the second messenger function of ceramide The Journal of Biological Chemistry 269 3125 3128 1:CAS:528:DyaK2cXhvVOkt74%3D 8106344
39. YA Hannun 1996 Functions of ceramide in coordinating cellular responses to stress Science 274 1855 1859 1:CAS:528:DyaK28XnsFGisrc%3D 10.1126/science.274.5294.1855 8943189 (Pubitemid 26424756)
40. YA Hannun LM Obeid 2008 Principles of bioactive lipid signalling: lessons from sphingolipids Nature Reviews. Molecular Cell Biology 9 139 150 1:CAS:528:DC%2BD1cXovFOntg%3D%3D 10.1038/nrm2329 18216770 (Pubitemid 351158911)
41. H Hida S Nagano M Takeda B Soliven 1999 Regulation of mitogen-activated protein kinases by sphingolipid products in oligodendrocytes Journal of Neuroscience 19 7458 7467 1:CAS:528:DyaK1MXlslWmsrk%3D 10460252 (Pubitemid 29404602)
42. H Hida M Takeda B Soliven 1998 Ceramide inhibits inwardly rectifying K+ currents via a Ras- and Raf-1-dependent pathway in cultured oligodendrocytes Journal of Neuroscience 18 8712 8719 1:CAS:528:DyaK1cXntFOlur4%3D 9786978 (Pubitemid 28491737)
43. K Itoh N Wakabayashi Y Katoh T Ishii T O'Connor M Yamamoto 2003 Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles Genes Cells 8 379 391 1:CAS:528:DC%2BD3sXivFOjuro%3D 10.1046/j.1365-2443.2003.00640.x 12653965 (Pubitemid 36504013)
44. AW Jahng I Maricic B Pedersen N Burdin O Naidenko M Kronenberg Y Koezuka V Kumar 2001 Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis The Journal of experimental medicine 194 1789 1799 1:CAS:528:DC%2BD38Xpt1ah 10.1084/jem.194.12.1789 11748280 (Pubitemid 34028658)
45. M Jana K Pahan 2005 Redox regulation of cytokine-mediated inhibition of myelin gene expression in human primary oligodendrocytes Free Radical Biology and Medicine 39 823 831 1:CAS:528:DC%2BD2MXos1aisLk%3D 10.1016/j.freeradbiomed. 2005.05.014 16109311 (Pubitemid 41139895)
46. A Jana K Pahan 2007 Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: Implications for multiple sclerosis Journal of Neuroimmune Pharmacology 2 184 193 10.1007/s11481-007-9066-2 18040843
47. S Jayadev HL Hayter N Andrieu CJ Gamard B Liu R Balu M Hayakawa F Ito YA Hannun 1997 Phospholipase A2 is necessary for tumor necrosis factor alpha-induced ceramide generation in L929 cells The Journal of biological chemistry 272 17196 17203 1:CAS:528:DyaK2sXksVeltrY%3D 10.1074/jbc.272.27.17196 9202042 (Pubitemid 27289833)
48. BH Juurlink SK Thorburne L Hertz 1998 Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress Glia 22 371 378 1:STN:280:DyaK1c7ns1OntA%3D%3D 10.1002/(SICI)1098-1136(199804)22:4<371::AID- GLIA6>3.0.CO;2-6 9517569 (Pubitemid 28129714)
49. JL Kanter S Narayana PP Ho I Catz KG Warren RA Sobel L Steinman WH Robinson 2006 Lipid microarrays identify key mediators of autoimmune brain inflammation Nature Medicine 12 138 143 1:CAS:528:DC%2BD28Xht1KmsQ%3D%3D 10.1038/nm1344 16341241 (Pubitemid 43050089)
50. L Kappos J Antel G Comi X Montalban P O'Connor CH Polman T Haas AA Korn G Karlsson EW Radue 2006 Oral fingolimod (FTY720) for relapsing multiple sclerosis New England Journal of Medicine 355 1124 1140 1:CAS:528: DC%2BD28XpsFKku78%3D 10.1056/NEJMoa052643 16971719 (Pubitemid 44394919)
51. N Kasai AR Pachner RK Yu 1986 Anti-glycolipid antibodies and their immune complexes in multiple sclerosis Journal of the Neurological Sciences 75 33 42 1:STN:280:DyaL28zgs1yktA%3D%3D 10.1016/0022-510X(86)90048-1 2427659 (Pubitemid 16056243)
52. R Kolesnick DW Golde 1994 The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling Cell 77 325 328 1:CAS:528:DyaK2cXjt1Srsbs%3D 10.1016/0092-8674(94)90147-3 8181053 (Pubitemid 24145193)
53. RN Kolesnick A Haimovitz-Friedman Z Fuks 1994 The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation Biochemistry and Cell Biology 72 471 474 1:CAS:528: DyaK2MXmtFShurk%3D 10.1139/o94-063 7544586
54. M Kunz SM Ibrahim 2009 Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity Mediators of Inflammation 2009 979258 10.1155/2009/979258 19884985
55. LB Laudiero L Aloe R Levi-Montalcini C Buttinelli D Schilter S Gillessen U Otten 1992 Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid Neuroscience Letters 147 9 12 1:CAS:528:DyaK3sXjslSktw%3D%3D 10.1016/0304-3940(92)90762-V 1480330
56. SM LeVine 1991 Oligodendrocytes and myelin sheaths in normal, quaking and shiverer brains are enriched in iron Journal of Neuroscience Research 29 413 419 1:CAS:528:DyaK3MXltFais7o%3D 10.1002/jnr.490290317 1920537
57. BN Marbois KF Faull AL Fluharty S Raval-Fernandes LH Rome 2000 Analysis of sulfatide from rat cerebellum and multiple sclerosis white matter by negative ion electrospray mass spectrometry Biochimica et Biophysica Acta 1484 59 70 1:CAS:528:DC%2BD3cXhtlWku7o%3D 10685031 (Pubitemid 30103817)
58. R Martin HF McFarland DE McFarlin 1992 Immunological aspects of demyelinating diseases Annual Review of Immunology 10 153 187 1:CAS:528:DyaK38XltV2ntL4%3D 10.1146/annurev.iy.10.040192.001101 1375472
59. S Marusic MW Leach JW Pelker ML Azoitei N Uozumi J Cui MW Shen CM DeClercq JS Miyashiro BA Carito P Thakker DL Simmons JP Leonard T Shimizu JD Clark 2005 Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis The Journal of experimental medicine 202 841 851 1:CAS:528:DC%2BD2MXhtVegsLnN 10.1084/jem.20050665 16172261 (Pubitemid 41345972)
60. S Marusic P Thakker JW Pelker NL Stedman KL Lee JC McKew L Han X Xu SF Wolf AJ Borey J Cui MW Shen F Donahue M Hassan-Zahraee MW Leach T Shimizu JD Clark 2008 Blockade of cytosolic phospholipase A2 alpha prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses Journal of Neuroimmunology 204 29 37 1:CAS:528:DC%2BD1cXhtlartb7O 10.1016/j.jneuroim.2008.08.012 18829119
61. I Matei L Matei 2002 Cytokine patterns and pathogenicity in autoimmune diseases Romanian Journal of Internal Medicine 40 27 41 1:CAS:528: DC%2BD3sXnt12isr8%3D 15526538 (Pubitemid 36921085)
62. JM McCord MA Edeas 2005 SOD, oxidative stress and human pathologies: A brief history and a future vision Biomedicine and Pharmacotherapy 59 139 142 1:CAS:528:DC%2BD2MXjs1Kmtrg%3D 10.1016/j.biopha.2005.03.005 (Pubitemid 40603324)
63. DM McTigue RB Tripathi 2008 The life, death, and replacement of oligodendrocytes in the adult CNS Journal of Neurochemistry 107 1 19 1:CAS:528:DC%2BD1cXht1KgtLjP 10.1111/j.1471-4159.2008.05570.x 18643793
64. KK Menon SJ Piddlesden CC Bernard 1997 Demyelinating antibodies to myelin oligodendrocyte glycoprotein and galactocerebroside induce degradation of myelin basic protein in isolated human myelin Journal of Neurochemistry 69 214 222 1:CAS:528:DyaK2sXktV2ms7w%3D 10.1046/j.1471-4159.1997.69010214.x 9202313
65. RH Miller 2002 Regulation of oligodendrocyte development in the vertebrate CNS Progress in Neurobiology 67 451 467 1:CAS:528: DC%2BD38XnvVKjsr0%3D 10.1016/S0301-0082(02)00058-8 12385864 (Pubitemid 35232446)
66. EA Moscatelli E Isaacson 1969 Gas liquid chromatographic analysis of sphingosine bases in sphingolipids of human normal and multiple sclerosis cerebral white matter Lipids 4 550 555 1:CAS:528:DyaE3cXlt12nsw%3D%3D 10.1007/BF02531040 4312744
67. S Nagata P Golstein 1995 The Fas death factor Science 267 1449 1456 1:CAS:528:DyaK2MXktlClt7w%3D 10.1126/science.7533326 7533326
68. J Newcombe A Uddin R Dove B Patel L Turski Y Nishizawa T Smith 2008 Glutamate receptor expression in multiple sclerosis lesions Brain Pathology 18 52 61 10.1111/j.1750-3639.2007.00101.x 17924980
69. B Ohler K Graf R Bragg T Lemons R Coe C Genain J Israelachvili C Husted 2004 Role of lipid interactions in autoimmune demyelination Biochimica et Biophysica Acta 1688 10 17 1:CAS:528:DC%2BD2cXltV2iug%3D%3D 14732476 (Pubitemid 38366301)
70. K Ozawa G Suchanek H Breitschopf W Bruck H Budka K Jellinger H Lassmann 1994 Patterns of oligodendroglia pathology in multiple sclerosis Brain 117 Pt 6 1311 1322 10.1093/brain/117.6.1311 7820568
71. K Pahan FG Sheikh M Khan AM Namboodiri I Singh 1998 Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes The Journal of biological chemistry 273 2591 2600 1:CAS:528:DyaK1cXnvFSgtw%3D%3D 10.1074/jbc.273.5.2591 9446561 (Pubitemid 28133900)
72. SE Pfeiffer AE Warrington R Bansal 1993 The oligodendrocyte and its many cellular processes Trends in Cell Biology 3 191 197 1:CAS:528:DyaK3sXks1yltLY%3D 10.1016/0962-8924(93)90213-K 14731493 (Pubitemid 23156606)
73. I Plo S Ghandour AC Feutz M Clanet G Laurent A Bettaieb 1999 Involvement of de novo ceramide biosynthesis in lymphotoxin-induced oligodendrocyte death Neuroreport 10 2373 2376 1:CAS:528:DyaK1MXltlGjuro%3D 10.1097/00001756- 199908020-00028 10439466 (Pubitemid 29367941)
74. M Podbielska EL Hogan 2009 Molecular and immunogenic features of myelin lipids: Incitants or modulators of multiple sclerosis? Multiple Sclerosis 15 1011 1029 1:CAS:528:DC%2BD1MXht1agtr7P 10.1177/1352458509106708 19692432
75. L Probert HP Eugster K Akassoglou J Bauer K Frei H Lassmann A Fontana 2000 TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease Brain 123 Pt 10 2005 2019 10.1093/brain/123.10.2005 11004118
76. CS Raine AB Johnson DM Marcus A Suzuki MB Bornstein 1981 Demyelination in vitro. Absorption studies demonstrate that galactocerebroside is a major target Journal of the Neurological Sciences 52 117 131 1:STN:280: DyaL38%2FlsVyhsg%3D%3D 10.1016/0022-510X(81)90140-4 6170737 (Pubitemid 11018934)
77. H Rosen EJ Goetzl 2005 Sphingosine 1-phosphate and its receptors: An autocrine and paracrine network Nature Reviews Immunology 5 560 570 1:CAS:528:DC%2BD2MXlsl2itr4%3D 10.1038/nri1650 15999095 (Pubitemid 40961333)
78. KA Sabelko-Downes AH Cross JH Russell, et al. 1999 Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis The Journal of experimental medicine 189 1195 1205 1:CAS:528:DyaK1MXisF2iu7Y%3D 10.1084/jem.189.8.1195 10209037 (Pubitemid 29198258)
79. KA Sabelko-Downes JH Russell AH Cross, et al. 1999 Role of Fas-FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease Journal of Neuroimmunology 100 42 52 1:CAS:528:DC%2BD3cXltVeitg%3D%3D 10.1016/S0165-5728(99)00191-5 10695714 (Pubitemid 30038237)
80. E Schonfeld I Yasharel E Yavin A Brand 2007 Docosahexaenoic acid enhances iron uptake by modulating iron transporters and accelerates apoptotic death in PC12 cells Neurochemical Research 32 1673 1684 1:CAS:528:DC%2BD2sXhtVGmsL3K 10.1007/s11064-007-9378-x 17551831 (Pubitemid 47428861)
81. D Schubert D Piasecki 2001 Oxidative glutamate toxicity can be a component of the excitotoxicity cascade Journal of Neuroscience 21 7455 7462 1:CAS:528:DC%2BD3MXnsFCksrY%3D 11567035 (Pubitemid 32904944)
82. B Segui O Cuvillier S Adam-Klages V Garcia S Malagarie-Cazenave S Leveque S Caspar-Bauguil J Coudert R Salvayre M Kronke T Levade 2001 Involvement of FAN in TNF-induced apoptosis Journal of Clinical Investigation 108 143 151 1:CAS:528:DC%2BD3MXkvVarsLw%3D 11435466 (Pubitemid 32634931)
83. I Singh K Pahan M Khan AK Singh 1998 Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases The Journal of biological chemistry 273 20354 20362 1:CAS:528:DyaK1cXlsVWgtLk%3D 10.1074/jbc.273.32.20354 9685387 (Pubitemid 28377600)
84. KJ Smith R Kapoor PA Felts 1999 Demyelination: The role of reactive oxygen and nitrogen species Brain Pathology 9 69 92 1:CAS:528:DyaK1MXht1CmsLc%3D 10.1111/j.1750-3639.1999.tb00212.x 9989453 (Pubitemid 29056521)
85. S Spiegel S Milstien 2003 Sphingosine-1-phosphate: An enigmatic signalling lipid Nature Reviews. Molecular Cell Biology 4 397 407 1:CAS:528:DC%2BD3sXjtlalt7o%3D 10.1038/nrm1103 12728273 (Pubitemid 36565571)
86. W Stoffel A Bosio 1997 Myelin glycolipids and their functions Current Opinion in Neurobiology 7 654 661 1:CAS:528:DyaK2sXnsVOis7s%3D 10.1016/S0959-4388(97)80085-2 9384539 (Pubitemid 27500825)
87. M Tani AR Glabinski VK Tuohy MH Stoler ML Estes RM Ransohoff 1996 In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis American Journal of Pathology 148 889 896 1:STN:280: DyaK28zntVantQ%3D%3D 8774143 (Pubitemid 126660680)
88. M Tani YA Hannun 2007 Neutral sphingomyelinase 2 is palmitoylated on multiple cysteine residues. Role of palmitoylation in subcellular localization The Journal of biological chemistry 282 10047 10056 1:CAS:528: DC%2BD2sXjtlCisLk%3D 10.1074/jbc.M611249200 17272284 (Pubitemid 47104605)
89. RK Thimmulappa KH Mai S Srisuma TW Kensler M Yamamoto S Biswal 2002 Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray Cancer Research 62 5196 5203 1:CAS:528:DC%2BD38Xnt1yns7Y%3D 12234984 (Pubitemid 35033454)
90. BD Trapp KA Nave 2008 Multiple sclerosis: An immune or neurodegenerative disorder? Annual Review of Neuroscience 31 247 269 1:CAS:528: DC%2BD1cXpt12nsrY%3D 10.1146/annurev.neuro.30.051606.094313 18558855
91. A Van der Goes D Wouters SM Van Der Pol R Huizinga E Ronken P Adamson J Greenwood CD Dijkstra HE De Vries 2001 Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro FASEB Journal 15 1852 1854 11481252
92. ME van Meeteren CE Teunissen CD Dijkstra EA van Tol 2005 Antioxidants and polyunsaturated fatty acids in multiple sclerosis European Journal of Clinical Nutrition 59 1347 1361 10.1038/sj.ejcn.1602255 16118655 (Pubitemid 43135149)
93. CL Vanderlugt SD Miller 2002 Epitope spreading in immune-mediated diseases: Implications for immunotherapy Nature Reviews Immunology 2 85 95 1:CAS:528:DC%2BD38XitFSnu7w%3D 10.1038/nri724 11910899
94. D Wheeler VV Bandaru PA Calabresi A Nath NJ Haughey 2008 A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis Brain 131 3092 3102 10.1093/brain/awn190 18772223
95. YP Wu K Mizugishi M Bektas R Sandhoff RL Proia 2008 Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease Human Molecular Genetics 17 2257 2264 1:CAS:528:DC%2BD1cXoslCisbg%3D 10.1093/hmg/ddn126 18424450
96. SO Yoon P Casaccia-Bonnefil B Carter MV Chao 1998 Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival Journal of Neuroscience 18 3273 3281 1:CAS:528:DyaK1cXivFCgsLo%3D 9547236 (Pubitemid 28186020)
97. SS Zamvil L Steinman 2003 Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis Neuron 38 685 688 1:CAS:528:DC%2BD3sXkslOlsrk%3D 10.1016/S0896-6273(03)00326-X 12797954 (Pubitemid 36694776)
98. L Zecca MB Youdim P Riederer JR Connor RR Crichton 2004 Iron, brain ageing and neurodegenerative disorders Nature Reviews 5 863 873 1:CAS:528:DC%2BD2cXos1Ojtrc%3D 10.1038/nrn1537 15496864 (Pubitemid 39482155)
99. X Zhang M Haaf B Todorich E Grosstephan H Schieremberg N Surguladze JR Connor 2005 Cytokine toxicity to oligodendrocyte precursors is mediated by iron Glia 52 199 208 10.1002/glia.20235 15968631 (Pubitemid 43078509)
100. Y Zhang R Kolesnick 1995 Signaling through the sphingomyelin pathway Endocrinology 136 4157 4160 1:CAS:528:DyaK2MXot1WmtLc%3D 10.1210/en.136.10.4157 7664631